Merck & Co

Merck in Discussion with Cubist Pharmaceuticals for Acquiring the Company

Merck in Discussion with Cubist Pharmaceuticals for Acquiring the CompanyReportedly Merck & Co. is in discussion with Cubist Pharmaceuticals Inc. in order to buy the Lexington, Mass. based antibiotics maker. The deal is expected to be worth greater than $7 billion.

Merck puts focus on Idenix drug for hepatitis C

Merck puts focus on Idenix drug for hepatitis CMerck & Co. is making a record wager that a trial ailment medicine is worth more than Coppertone and Dr. Scholl's.

HPV Vaccine Gardasil Recalled As Some May Carry Small Glass Pieces

GardasilAccording to a latest report, the drug manufacturing company Merck & Co. has recently recalled for its HPV (Human papillomavirus) vaccines.

It has been revealed by the sources that Merck & Co. has recently issued a voluntary recall for one of its HPV (Human papillomavirus) vaccines. This vaccine is known as Gardasil as per the company.

Appeals Court Rules in Favor of Merck

Appeals Court Rules in Favor of MerckA recent report confirmed that Merck & Co. (MRK) has managed to get a US appeals court ruling in its favour, which would prohibit Mylan Inc. (MYL) from selling a generic version of the Zetia and Vytorin cholesterol medicines before April 2014 when the patent expires.

Merck disappointed from Cancer Vaccine’s result

Cancer-VaccineAs per reports, it has been revealed by German pharmaceutical company Merck KGaA that their experimental cancer vaccine formerly known as Stimuvax has failed to provide the desired end result. The clinical trial was in its phase three stage.

Phase II Trials of Alzheimer’s Drug Begins

Phase II Trials of Alzheimer’s Drug BeginsMK-8931, a newly developed drug against the Alzheimer's disease, has begun with the Phase II trials in which the patients with the different level of disease will be given the drug to check the safety and effectiveness of the same.

Pages